Orange Biomed
PrivateLast Round
Series A
Extension
Dec 10, 2024
Total Funding Raised
$3.51M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Orange Biomed operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series A Extension round in December 2024.
Orange Biomed is a healthcare technology company that develops portable, microfluidic-based devices for measuring glycated hemoglobin (A1c) levels to improve diabetes management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orange Biomed Comparables
Compare Orange Biomed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sinocare Inc. | 74% | |
| AstraZeneca | 73% | |
| Abbott Laboratories | 72% |
For institutional investors. Book with your work email.
Orange Biomed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 10, 2024 | ||||
| Early Funding | Aug 10, 2022 |
For institutional investors. Book with your work email.
Orange Biomed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| K2 Investment Partners | Series A Extension |
| Digital Healthcare Partners | Early Funding |
| 디지털 헬스케어 파트너스 | Early Funding |
| Seoul New Technology Investment Co. | Early Funding |
| Intops Investment | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 307% MoM to 3.2K.
- Nov 10, 2025
Will attend MEDICA 2025 to showcase A1C test.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 18, 2026
Orange Biomed participates in the 2026 Breakthrough T1D Triangle Walk in North Carolina on Nov 8th '26, reinforcing its commitment to public awareness, advocacy, and health accessibility.
For institutional investors. Book with your work email.
Orange Biomed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Orange Biomed's valuation, stock price, and market status.
Is Orange Biomed a public or private company?
Orange Biomed is a private company.
What is the current stock price of Orange Biomed?
Orange Biomed is a private company, so its shares have no public market price. Caplight tracks Orange Biomed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Orange Biomed worth (valuation)?
Valuation information for Orange Biomed is not publicly available.
Can I buy Orange Biomed stock?
Orange Biomed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Orange Biomed's last funding round?
Orange Biomed's most recent funding round was Series A Extension on December 10, 2024.
Who are the main investors in Orange Biomed?
Key investors in Orange Biomed include K2 Investment Partners, Digital Healthcare Partners, 디지털 헬스케어 파트너스, Seoul New Technology Investment Co., Intops Investment.
Will Orange Biomed IPO soon?
No public IPO plans have been announced for Orange Biomed.
How can I track Orange Biomed secondary market activity?
Caplight tracks bids, offers, and trades in Orange Biomed's shares on secondary markets.